Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot‐Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report
IJU Case Reports · 2026-09 · 9 (5)
DOI: 10.1002/iju5.70252 ↗Kurz gefasst
Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 18.08.2026. Verfasst von Kazuma Soya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Squamous cell carcinoma is a rare bladder cancer subtype with poor prognosis in advanced stages. Currently, there is no established systemic therapy, including immune checkpoint inhibitors, for this subtype. Case Presentation A 49‐year‐old man with pure bladder squamous cell carcinoma arising from a diverticulum with pelvic lymph node involvement underwent neoadjuvant gemcitabine plus cisplatin followed by robot‐assisted radical cystectomy. Six months later, pulmonary metastases developed, and platinum rechallenge led to rapid progression with pleural dissemination. Pembrolizumab produced a complete response despite programmed cell death ligand‐1 negativity, microsatellite stability, and low tumor mutational burden. Isolated hilar lymph node progression during treatment was managed with radiotherapy, achieving temporary local control. The patient survived 41 months from diagnosis and 30 months after metastasis.
Conclusion
Despite early and aggressive metastatic recurrence after robot‐assisted radical cystectomy, the patient showed a remarkable and durable response to pembrolizumab.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.
- Department of Medical Oncology Hyogo Cancer Center Akashi Hyogo Japan.
- Department of Diagnostic Pathology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.
- Department of Radiology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.
ORCID-Profile: Kazuma Soya, Takeru Fujimoto
Zitieren
APA
Soya, K., Fujimoto, T., Osaki, Y., Matsumoto, K., Takei, Y., Sugino, Y., Maruta, T., & Iwamura, H. (2026). Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot‐Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report. IJU Case Reports, 9(5). https://doi.org/10.1002/iju5.70252
Vancouver
Soya K, Fujimoto T, Osaki Y, Matsumoto K, Takei Y, Sugino Y, et al. Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot‐Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report. IJU Case Reports. 2026;9(5). doi:10.1002/iju5.70252
BibTeX
@article{Soya2026,
author = {Soya, Kazuma and Fujimoto, Takeru and Osaki, Yu and Matsumoto, Koji and Takei, Yusuke and Sugino, Yoshio and Maruta, Tsutomu and Iwamura, Hiroshi},
title = {Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot‐Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report},
journal = {IJU Case Reports},
year = {2026},
volume = {9},
number = {5},
doi = {10.1002/iju5.70252}
}
EUVIMED